4SC AG: 4SC publishes Q1 2024 report
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
4SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage c…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Removes the requirement to conduct paediatric clinical studies when the development of the medicine is not needed or is…
Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cut…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Gold is not only an excellent means of preserving value for investors but is also becoming increasingly important in med…
MHH spin-off Cardior will be taken over for up to EUR 1.025 billion including an upfront payment and additional paym…